18593-4 |
Discharged from origin institution |
Find |
Ambulance transport |
Pt |
Ord |
|
|
ACTIVE |
Ambulance transport, Discharged from origin institution |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.AMB |
|
18593-4 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.AMB; Facility; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18594-2 |
Rehabilitation.psychiatric service attachment |
Find |
{Setting} |
Pt |
Doc |
{Role} |
|
ACTIVE |
Psychiatric service attachment |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
18594-2 |
|
{Role} |
|
|
Both |
|
|
|
0 |
Rehab.psych therapy service Doc |
|
|
|
|
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Rehab.psych therapy service |
2.73 |
1.0l |
Y |
|
|
|
|
|
|
|
|
|
Based on Clinical LOINC Committee decision during the September 2014 meeting, {Provider} was changed to {Author Type} to emphasize a greater breadth of potential document authors. At the September 2015 Clinical LOINC Committee meeting, the Committee decided to change {Author Type} to {Role} to align with the 'Role' axis name in the LOINC Document Ontology.; Updated Class from "ATTACH.REHAB" to "DOC.MISC". |
0 |
18598-3 |
Control number identification.claims attachment |
ID |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Control number identification.claims attachment |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH |
|
18598-3 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
Control # identification.claims attachment; Ident; Identifier; No; Nominal; Num; Point in time; Random |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
186-7 |
Ciprofloxacin |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Ciprofloxacin [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
186-7 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Ciprofloxacin Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
1860-6 |
Angiotensin II |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Angiotensin II [Mass/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
1860-6 |
|
|
|
|
Both |
|
|
|
0 |
Angiotensin II Plas-mCnc |
|
|
|
Y |
|
2; AGT; Angiotensin 2; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
18600-7 |
Primary practitioner ID |
ID |
Provider |
Pt |
Nom |
|
|
ACTIVE |
Primary practitioner identifier |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH |
|
18600-7 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; Ident; Identifier; Intradermal; Nominal; Point in time; Primary pract ID; Random |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
Answer list changed from Normative as results can be another identifier other than NPI. |
0 |
18601-5 |
Primary practitioner profession |
Type |
Provider |
Pt |
Nom |
|
|
ACTIVE |
Primary practitioner profession |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH |
|
18601-5 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; Nominal; Point in time; Primary pract profession; Random; Typ |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18602-3 |
ED practitioner ID |
ID |
Provider |
Pt |
Nom |
|
|
ACTIVE |
ED practitioner identifier |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH |
|
18602-3 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ED pract ID; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Random |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
Answer list changed from Normative as results can be another identifier other than NPI. |
0 |
18605-6 |
Medication.current |
Cmplx |
^Patient |
Pt |
Set |
Reported |
|
ACTIVE |
Medication current Set |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18605-6 |
|
Reported |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Complex; MEDS; Point in time; Random |
2.73 |
1.0l |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
18606-4 |
Name + ID |
ID |
Medication.current |
Pt |
Nom |
|
|
ACTIVE |
Current medication, Name and Identifier |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18606-4 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Ident; Identifier; Intradermal; Med; MEDS; Nominal; Point in time; Random |
2.4 |
1.0l |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
18607-2 |
Medication XXX |
Dosage |
Medication.current |
Pt |
Qn |
|
|
ACTIVE |
Current medication Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18607-2 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
Y |
|
ATTACH; ATTACH.MEDS; Med; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18608-0 |
Timing + Quantity |
TQ2 |
Medication.current |
Pt |
Qn |
|
|
ACTIVE |
Current medication, Timing + Quantity |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18608-0 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Med; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Timing - quantity |
2.42 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18609-8 |
Route |
Prid |
Medication.current |
Pt |
Nom |
|
|
ACTIVE |
Current medication, Route |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18609-8 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Identity or presence; Med; MEDS; Nominal; Point in time; Random |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
1861-4 |
Angiotensinogen |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Angiotensinogen [Mass/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
1861-4 |
|
|
|
|
Both |
|
|
|
0 |
Angiotensinogen Plas-mCnc |
|
|
|
Y |
|
Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
18610-6 |
Medication.administered |
Cmplx |
^Patient |
Pt |
Set |
|
|
ACTIVE |
Medication administered Set |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18610-6 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Complex; Medication administered; MEDS; Point in time; Random |
2.63 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18611-4 |
Name + ID |
ID |
Medication.administered |
Pt |
Nom |
|
|
ACTIVE |
Administered medication, Name and Identifier |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18611-4 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Ident; Identifier; Intradermal; Med; MEDS; Nominal; Point in time; Random |
2.4 |
1.0l |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
18612-2 |
Route |
Prid |
Medication.administered |
Pt |
Nom |
|
|
ACTIVE |
Administered medication, Route |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18612-2 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Identity or presence; Med; MEDS; Nominal; Point in time; Random |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18614-8 |
Timing |
TQ2 |
Medication.administered |
Pt |
Qn |
|
|
ACTIVE |
Administered medication, Timing |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18614-8 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Med; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Timing - quantity |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18615-5 |
Medication XXX |
Dosage |
Medication.administered |
Pt |
Qn |
|
|
ACTIVE |
Medication administered Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18615-5 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
Y |
|
ATTACH; ATTACH.MEDS; Med; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18616-3 |
Strength |
Prid |
Medication.administered |
Pt |
Nom |
|
|
ACTIVE |
Administered medication, Strength |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18616-3 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
Y |
|
ATTACH; ATTACH.MEDS; Identity or presence; Med; MEDS; Nominal; Point in time; Random |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18617-1 |
Medication.discharge |
Cmplx |
^Patient |
Pt |
Set |
|
|
ACTIVE |
Medication discharge Set |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18617-1 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Complex; Disch; MEDS; Point in time; Random |
2.4 |
1.0l |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
18618-9 |
Name + ID |
ID |
Medication.discharge |
Pt |
Nom |
|
|
ACTIVE |
Discharge medication, Name and Identifier |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18618-9 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Disch; Ident; Identifier; Intradermal; Med; MEDS; Nominal; Point in time; Random |
2.4 |
1.0l |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
18619-7 |
Medication XXX |
Dosage |
Medication.discharge |
Pt |
Qn |
|
|
ACTIVE |
Discharge medication Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18619-7 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
Y |
|
ATTACH; ATTACH.MEDS; Disch; Med; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
1862-2 |
Aniline |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aniline [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
1862-2 |
|
|
|
|
Both |
|
|
|
0 |
Aniline SerPl-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenylamine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
18620-5 |
Timing + Quantity |
TQ2 |
Medication.discharge |
Pt |
Qn |
|
|
ACTIVE |
Discharge medication, Timing + Quantity |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.MEDS |
|
18620-5 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.MEDS; Disch; Med; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Timing - quantity |
2.42 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |